دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States Population
Gaurav Khandelwal, MD, Alessandro Spirito, MD, Richard Tanner, MD, Anoop N. Koshy, MD, PHD, Samantha Sartori, PHD, Negar Salehi, MD, Gennaro Giustino, MD, Vishal Dhulipala, MD, Zhongjie Zhang, MPH, Jaime Gonzalez, BA, Amit Hooda, MD, Manish Vinayak, MD, Asif Shaikh, MD, Roxana Mehran, MD, Annapoorna S. Kini, MD, Samin K. Sharma, MD
doi : 10.1016/j.jcin.2023.02.005
Volume 16, Issue 9, 8 May 2023, Pages 1011-1020
A complex high-risk indicated percutaneous coronary intervention (CHIP) score was recently developed from the British Cardiovascular Intervention Society (BCIS) database to define CHIP cases and their risk of in-hospital major adverse cardiac or cerebrovascular events (MACCE).
CHIP Score: Are We Almost There or Is Reproducibility a Problem?∗
Marwan Saad, MD, PHD, a,b J. Dawn Abbott, MD
doi : 10.1016/j.jcin.2023.03.016
Volume 16, Issue 9, 8 May 2023, Pages 1021-1023
Impact of Eruptive vs Noneruptive Calcified Nodule Morphology on Acute and Long-Term Outcomes After Stenting
Takao Sato, MD,a,b,c Mitsuaki Matsumura, BS, a Kei Yamamoto, MD, a,b,c Evan Shlofmitz, DO, b Jeffrey W. Moses, MD, a,b,c Omar K. Khalique, MD,a,b Susan V. Thomas, MPH,b Anna Tsoulios,b David J. Cohen, MD, MS C,a,b Gary S. Mintz, MD,a Richard A. Shlofmitz, MD, b Allen Jeremias, MD, MS C,a,b Ziad A. Ali, MD, DPHIL ,a,b Akiko Maehara, MD
doi : 10.1016/j.jcin.2023.03.009
Volume 16, Issue 9, 8 May 2023, Pages 1024-1035
Whether an eruptive or noneruptive target lesion calcified nodule (CN) portends worse acute and long-term clinical outcomes after stenting has not been established.
The Calcified Nodule Paradox∗
Brigitta C. Brott, MD
doi : 10.1016/j.jcin.2023.04.001
Volume 16, Issue 9, 8 May 2023, Pages 1036-1038
The Association Between Angiographically Derived Radial Wall Strain and the Risk of Acute Myocardial Infarction
Chenguang Li, MD, a, * Zhiqing Wang, MD,b,c, * Hao Yang, MD,a Huihong Hong, MD,d Chunming Li, BS C,c Rende Xu, MD, a Yizhe Wu, MD,a Feng Zhang, MD,a Juying Qian, MD, a Lianglong Chen, MD, P HD, b Shengxian Tu, PHD, c Junbo Ge, MD
doi : 10.1016/j.jcin.2023.02.012
Volume 16, Issue 9, 8 May 2023, Pages 1039-1049
The radial wall strain (RWS) is a novel angiography-based method to assess the biomechanical property of the coronary artery and whether it can predict future acute myocardial infarction (AMI) events remains to be elucidated.
Vascular Biomechanics: The True Apex of the Cardiovascular Risk Pyramid?∗
David Molony, P HD, Habib Samady, MD
doi : 10.1016/j.jcin.2023.03.041
Volume 16, Issue 9, 8 May 2023, Pages 1050-1053
Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up
Bernardo Cortese, MD, a,b Gabriella Testa, MD,c Fernando Rivero, MD, d Andrea Erriquez, MD,e Fernando Alfonso, MD
doi : 10.1016/j.jcin.2023.02.011
Volume 16, Issue 9, 8 May 2023, Pages 1054-1061
Native vessel coronary artery disease represents 1 of the most attractive fields of application for drug-coated balloons (DCBs). To date, several devices have been compared with drug-eluting stents (DESs) in this setting with different outcomes.
Drug-Coated Balloons in Small Vessels: Preferred Strategy to Drug-Eluting Stents?∗
J. Dawn Abbott, MD,a Joanna J. Wykrzykowska, MD, P HD, b Chris Lenselink, BSC
doi : 10.1016/j.jcin.2023.03.005
Volume 16, Issue 9, 8 May 2023, Pages 1062-1064
5-Year Outcomes of Drug-Coated Balloons for Peripheral Artery In-Stent Restenosis, Long Lesions, and CTOs
Gunnar Tepe, MD, PH D, a Marianne Brodmann, MD, PH D, b Antonio Micari, MD, PH D, c Dierk Scheinert, MD, PHD, d Donghoon Choi, MD, P HD, e Jeremiah Menk, MS, f Thomas Zeller, MD, PH D, g on behalf of the IN.PACT Global Study Investigators
doi : 10.1016/j.jcin.2023.03.032
Volume 16, Issue 9, 8 May 2023, Pages 1065-1078
Long-term data on drug-coated balloon (DCB) outcomes in complex femoropopliteal atherosclerotic lesions are limited.
It Is Challenging to Interpret Results of Drug-Coated Balloon Treatment for Challenging Lesions∗
Osamu Iida, MD, P HD, a Mitsuyoshi Takahara, MD, PHD, b,c Yoshiharu Higuchi, MD, P HD a
doi : 10.1016/j.jcin.2023.04.002
Volume 16, Issue 9, 8 May 2023, Pages 1079-1080
Impact of Right Ventricular Pacing in Patients With TAVR Undergoing Permanent Pacemaker Implantation
Francesco Bruno, MD,a Isabel Munoz Pousa, MD,b Francesco Saia, MD, c Matteo Pio Vaira, MD,a Enrico Baldi, MD, d Pier Pasquale Leone, MD,e Pilar Cabanas-Grandio, MD, b Nicola Corcione, MD,f Enrico Guido Spinoni, MD,g Gianmarco Annibali, MD, h Caterina Russo, MD, a Matteo Ziacchi, MD, c Carlo Alberto Caruzzo, MD, a Marco Ferlini, MD, d Giuseppe Lanzillo, MD, d Ovidio De Filippo, MD, a Veronica Dusi, MD, a Guglielmo Gallone, MD,a Davide Castagno, MD, a Giuseppe Patti, MD,g Michele La Torre, MD, i Giuseppe Musumeci, MD, h Arturo Giordano, MD,f Giulio Stefanini, MD,e,j Stefano Salizzoni, MD, i Federico Conrotto, MD, a Mauro Rinaldi, MD, i Roberto Rordorf, MD, d Emad Abu-Assi, MD,b Sergio Raposeiras-Roubin, MD,b Mauro Biffi, MD,c Fabrizio D’Ascenzo, MD, PHD, a, * Gaetano Maria De Ferrari, MD
doi : 10.1016/j.jcin.2023.02.003
Volume 16, Issue 9, 8 May 2023, Pages 1081-1091
Long-term right ventricular pacing (VP) has been related to negative left ventricular remodeling and heart failure (HF), but there is a lack of evidence regarding the prognostic impact on transcatheter aortic valve replacement (TAVR) patients.
Pacing After TAVR: Just Give Me the Beat, But Improve the Instruments∗
Steven J. Yakubov, MD, a Anish Amin, MD
doi : 10.1016/j.jcin.2023.03.040
Volume 16, Issue 9, 8 May 2023, Pages 1092-1094
Sex Differences in Outcomes After Transcatheter Aortic Valve Replacement: A POPular TAVI Subanalysis
Kees H. van Bergeijk, MD, a, * Dirk-Jan van Ginkel, MD, b, * Jorn Brouwer, MD, P HD, b Vincent J. Nijenhuis, MD, PHD, b Hindrik W. van der Werf, MD,a Ad F.M. van den Heuvel, MD, PH D, a Adriaan A. Voors, MD, PH D, a Joanna J. Wykrzykowska, MD, PH D, a Jurriën M. ten Berg, MD, PH D
doi : 10.1016/j.jcin.2023.02.039
Volume 16, Issue 9, 8 May 2023, Pages 1095-1102
Sex, Antithrombotics, and Outcomes After TAVR: Is There More Difference Within Sexes or Between Them?∗
Giulia Masiero, MD, Giuseppe Tarantini, MD, P HD
doi : 10.1016/j.jcin.2023.03.051
Volume 16, Issue 9, 8 May 2023, Pages 1103-1106
Coronary CT-Guided Minimalistic Hybrid Approach for Percutaneous Chronic Total Occlusion Recanalization
Enrico Poletti, MD, a Hirofumi Ohashi, MD, PHD, b Jeroen Sonck, MD, P HD, b Gianluca Castaldi, MD, a Alice Benedetti, MD, a Carlos Collet, MD, PHD, b Pierfrancesco Agostoni, MD, P HD, a Carlo Zivelonghi, MD, P HD, MS C
doi : 10.1016/j.jcin.2023.03.013
Volume 16, Issue 9, 8 May 2023, Pages 1107-1108
Fenestration of a PK Papyrus Stent From an Extraplaque Space Into the True Lumen
Salman S. Allana, MD, Judit Karacsonyi, MD, PH D, Spyridon Kostantinis, MD, Bahadir Simsek, MD, Athanasios Rempakos, MD, Emmanouil S. Brilakis, MD, PH D
doi : 10.1016/j.jcin.2023.02.033
Volume 16, Issue 9, 8 May 2023, Pages 1109-1112
Simplified Interventional Treatment of Distal Wire–Related Perforation: The “Plug and Seal Technique�
Hady Lichaa, MD
doi : 10.1016/j.jcin.2023.03.003
Volume 16, Issue 9, 8 May 2023, Pages 1113-1115
Positive Nuclear Stress Test After STEMI: Importance of Invasive Physiologic Assessment and Acetylcholine Testing
Edward T. Ha, MD, a Marline Attallah, MD,a Manish A. Parikh, MD, a,b Yuhei Kobayashi, MD
doi : 10.1016/j.jcin.2023.02.007
Volume 16, Issue 9, 8 May 2023, Pages 1116-1117
Microvascular Resistance Reserve in Coronary Slow Flow Phenomenon
Kenji Sadamatsu, MD, PhD Yoshihiro Fukumoto, MD, PhD
doi : 10.1016/j.jcin.2023.03.019
Volume 16, Issue 9, 8 May 2023, Page 1118
Reply: Microvascular Resistance Reserve in Coronary Slow Flow Phenomenon
Annemiek de Vos, MD Tijn Jansen, MD Nico Pijls, MD Peter Damman, MD
doi : 10.1016/j.jcin.2023.04.010
Volume 16, Issue 9, 8 May 2023, Page 1119
Splitting the Leaflets: Is There Any “ShortCut�?
Kyriakos Dimitriadis, MD Eirini Beneki, MD Konstantinos Tsioufis, MD
doi : 10.1016/j.jcin.2023.02.025
Volume 16, Issue 9, 8 May 2023, Page 1120
Reply: Splitting the Leaflets: Is There Any “ShortCut�?
*Danny Dvir, MD
doi : 10.1016/j.jcin.2023.04.006
Volume 16, Issue 9, 8 May 2023, Page 1121
Safety and Effectiveness of Coronary Intravascular Lithotripsy for Treatment of Calcified Nodules
Ziad A. Ali, MD, DPhil Dean Kereiakes, MD Jonathan Hill, MD Shigeru Saito, MD Carlo Di Mario, MD, PhD Benjamin Honton, MD Nieves Gonzalo, MD, PhD Robert Riley, MD Akiko Maehara, MD Mitsuaki Matsumura, BS Gregg W. Stone, MD Richard Shlofmitz, MD
doi : 10.1016/j.jcin.2023.02.015
Volume 16, Issue 9, 8 May 2023, Pages 1122-1124
A Next-Generation Balloon-Expandable Transcatheter Aortic Valve: First-in-Human Experience
David Meier, MDy Andrew G. Chatfield, MBChBy Mariama Akodad, MD, PhD Julius Jelisejevas, MD Fady Zaky, MD Ali Husain, MD Philipp Blanke, MD David A. Wood, MD Janarthanan Sathananthan, MBChB, MPH *John G. Webb, MD
doi : 10.1016/j.jcin.2023.02.014
Volume 16, Issue 9, 8 May 2023, Pages 1125-1127
